False Activations for ST-Segment Elevation Myocardial Infarction

David C. Lange; Ivan C. Rokos; J. Lee Garvey; David M. Larson; Timothy D Henry

doi:10.1016/j.iccl.2016.06.002

False Activations for ST-Segment Elevation Myocardial Infarction

David C. Lange
, Ivan C. Rokos
, J. Lee Garvey
, David M. Larson
, Timothy D Henry

Medicine - Cardiology Division

Research output: Contribution to journal › Review article › peer-review

15 Scopus citations

Abstract

First-medical-contact-to-device (FMC2D) times have improved over the past decade, as have clinical outcomes for patients presenting with ST-elevation myocardial infarction (STEMI). However, with improvements in FMC2D times, false activation of the cardiac catheterization laboratory (CCL) has become a challenging problem. The authors define false activation as any patient who does not warrant emergent coronary angiography for STEMI. In addition to clinical outcome measures for these patients, STEMI systems should collect data regarding the total number of CCL activations, the total number of emergency coronary angiograms, and the number revascularization procedures performed.

Original language	English (US)
Pages (from-to)	451-469
Number of pages	19
Journal	Interventional Cardiology Clinics
Volume	5
Issue number	4
DOIs	https://doi.org/10.1016/j.iccl.2016.06.002
State	Published - Oct 1 2016

Bibliographical note

Publisher Copyright:
© 2016 Elsevier Inc.

Keywords

Assessment
False activation
Primary percutaneous coronary intervention
Quality improvement
Quality outcomes
ST-elevation myocardial infarction
Systems of care

Publisher link

10.1016/j.iccl.2016.06.002

Find It

Find It at U of M Libraries

Cite this

@article{2c2481c6df4347c0831fc71649fdc90e,

title = "False Activations for ST-Segment Elevation Myocardial Infarction",

abstract = "First-medical-contact-to-device (FMC2D) times have improved over the past decade, as have clinical outcomes for patients presenting with ST-elevation myocardial infarction (STEMI). However, with improvements in FMC2D times, false activation of the cardiac catheterization laboratory (CCL) has become a challenging problem. The authors define false activation as any patient who does not warrant emergent coronary angiography for STEMI. In addition to clinical outcome measures for these patients, STEMI systems should collect data regarding the total number of CCL activations, the total number of emergency coronary angiograms, and the number revascularization procedures performed.",

keywords = "Assessment, False activation, Primary percutaneous coronary intervention, Quality improvement, Quality outcomes, ST-elevation myocardial infarction, Systems of care",

author = "Lange, \{David C.\} and Rokos, \{Ivan C.\} and Garvey, \{J. Lee\} and Larson, \{David M.\} and Henry, \{Timothy D\}",

note = "Publisher Copyright: {\textcopyright} 2016 Elsevier Inc.",

year = "2016",

month = oct,

day = "1",

doi = "10.1016/j.iccl.2016.06.002",

language = "English (US)",

volume = "5",

pages = "451--469",

journal = "Interventional Cardiology Clinics",

issn = "2211-7458",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - False Activations for ST-Segment Elevation Myocardial Infarction

AU - Lange, David C.

AU - Rokos, Ivan C.

AU - Garvey, J. Lee

AU - Larson, David M.

AU - Henry, Timothy D

PY - 2016/10/1

Y1 - 2016/10/1

N2 - First-medical-contact-to-device (FMC2D) times have improved over the past decade, as have clinical outcomes for patients presenting with ST-elevation myocardial infarction (STEMI). However, with improvements in FMC2D times, false activation of the cardiac catheterization laboratory (CCL) has become a challenging problem. The authors define false activation as any patient who does not warrant emergent coronary angiography for STEMI. In addition to clinical outcome measures for these patients, STEMI systems should collect data regarding the total number of CCL activations, the total number of emergency coronary angiograms, and the number revascularization procedures performed.

AB - First-medical-contact-to-device (FMC2D) times have improved over the past decade, as have clinical outcomes for patients presenting with ST-elevation myocardial infarction (STEMI). However, with improvements in FMC2D times, false activation of the cardiac catheterization laboratory (CCL) has become a challenging problem. The authors define false activation as any patient who does not warrant emergent coronary angiography for STEMI. In addition to clinical outcome measures for these patients, STEMI systems should collect data regarding the total number of CCL activations, the total number of emergency coronary angiograms, and the number revascularization procedures performed.

KW - Assessment

KW - False activation

KW - Primary percutaneous coronary intervention

KW - Quality improvement

KW - Quality outcomes

KW - ST-elevation myocardial infarction

KW - Systems of care

UR - https://www.scopus.com/pages/publications/85020324433

UR - https://www.scopus.com/pages/publications/85020324433#tab=citedBy

U2 - 10.1016/j.iccl.2016.06.002

DO - 10.1016/j.iccl.2016.06.002

M3 - Review article

C2 - 28581995

AN - SCOPUS:85020324433

SN - 2211-7458

VL - 5

SP - 451

EP - 469

JO - Interventional Cardiology Clinics

JF - Interventional Cardiology Clinics

IS - 4

ER -

False Activations for ST-Segment Elevation Myocardial Infarction

Abstract

Bibliographical note

Keywords

Publisher link

Find It

Other files and links

Fingerprint

Cite this